New Targets in Heart Failure Drug Therapy

Despite recent advances in chronic heart failure management (either pharmacological or non-pharmacological), the prognosis of heart failure (HF) patients remains poor. This poor prognosis emphasizes the need for developing novel pathways for testing new HF drugs, beyond neurohumoral and hemodynamic...

Descripción completa

Detalles Bibliográficos
Autores principales: Correale, Michele, Tricarico, Lucia, Fortunato, Martino, Mazzeo, Pietro, Nodari, Savina, Di Biase, Matteo, Brunetti, Natale Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131549/
https://www.ncbi.nlm.nih.gov/pubmed/34026873
http://dx.doi.org/10.3389/fcvm.2021.665797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131549/
https://www.ncbi.nlm.nih.gov/pubmed/34026873
http://dx.doi.org/10.3389/fcvm.2021.665797

Ejemplares similares